Show simple item record

dc.contributor.authorBates, DO
dc.contributor.authorBeazley-Long, N
dc.contributor.authorBenest, AV
dc.contributor.authorYe, X
dc.contributor.authorVed, N
dc.contributor.authorHulse, RP
dc.contributor.authorBarratt, S
dc.contributor.authorMachado, MJ
dc.contributor.authorDonaldson, LF
dc.contributor.authorHarper, SJ
dc.contributor.authorPeiris-Pages, M
dc.contributor.authorTortonese, DJ
dc.contributor.authorOltean, S
dc.contributor.authorFoster, RR
dc.date.accessioned2019-05-20T15:42:38Z
dc.date.issued2018-06-18
dc.description.abstractThe vascular endothelial growth factor (VEGF) family of proteins are key regulators of physiological systems. Originally linked with endothelial function, they have since become understood to be principal regulators of multiple tissues, both through their actions on vascular cells, but also through direct actions on other tissue types, including epithelial cells, neurons, and the immune system. The complexity of the five members of the gene family in terms of their different splice isoforms, differential translation, and specific localizations have enabled tissues to use these potent signaling molecules to control how they function to maintain their environment. This homeostatic function of VEGFs has been less intensely studied than their involvement in disease processes, development, and reproduction, but they still play a substantial and significant role in healthy control of blood volume and pressure, interstitial volume and drainage, renal and lung function, immunity, and signal processing in the peripheral and central nervous system. The widespread expression of VEGFs in healthy adult tissues, and the disturbances seen when VEGF signaling is inhibited support this view of the proteins as endogenous regulators of normal physiological function. This review summarizes the evidence and recent breakthroughs in understanding of the physiology that is regulated by VEGF, with emphasis on the role they play in maintaining homeostasis. © 2017 American Physiological Society. Compr Physiol 8:955-979, 2018.en_GB
dc.description.sponsorshipBritish Heart Foundationen_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.description.sponsorshipRichard Bright VEGF Research Trusten_GB
dc.identifier.citationVol. 8, pp. 955 - 979en_GB
dc.identifier.doi10.1002/cphy.c170015
dc.identifier.urihttp://hdl.handle.net/10871/37153
dc.language.isoenen_GB
dc.publisherWiley for American Physiological Societyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/29978898en_GB
dc.rights.embargoreasonUnder embargo until 18 June 2018 in compliance with publisher policy.en_GB
dc.rightsCopyright © 2018 American Physiological Society. All rights reserved.en_GB
dc.titlePhysiological role of vascular endothelial growth factors as homeostatic regulatorsen_GB
dc.typeArticleen_GB
dc.date.available2019-05-20T15:42:38Z
dc.identifier.issn2040-4603
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from the publisher via the DOI in this recorden_GB
dc.identifier.journalComprehensive Physiologyen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2018-06-18
rioxxterms.versionAMen_GB
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-05-20T15:17:22Z
refterms.versionFCDAM
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record